Population pharmacokinetics of abacavir in infants, toddlers and children-Reference-Cited by-同舟云学术

Population pharmacokinetics of abacavir in infants, toddlers and children

Published:2013-05-20 Issue:6 Volume:75 Page:1525-1535
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Zhao Wei,Piana Chiara¹,Danhof Meindert¹,Burger David²,Della Pasqua Oscar,Jacqz-Aigrain Evelyne

Affiliation:

1. LACDR; Division of Pharmacology; Leiden University; Leiden; The Netherlands

2. Department of Pharmacy & Nijmegen Institute for Infection; Inflammation and Immunity (N4i); Radboud University Nijmegen Medical Center; Nijmegen; The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12024/fullpdf

Reference22 articles.

1. International AIDS Society-USA. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel;Thompson;JAMA,2010

2. PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection;Welch;HIV Med,2009

3. Pharmacokinetics of [(14)C] abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1-infected adults: a mass balance study;McDowell;Antimicrob Agents Chemother,1999

4. A review of the pharmacokinetics of abacavir;Yuen;Clin Pharmacokinet,2008

5. Unique intracellular activation of the potent anti-human immunodeficiency virus agent 1592U89;Faletto;Antimicrob Agents Chemother,1997

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abacavir Drug Exposures in African Children Under 14 kg Using Pediatric Solid Fixed Dose Combinations According to World Health Organization Weight Bands;Journal of the Pediatric Infectious Diseases Society;2023-10-05

2. Paediatric medicine issues and gaps from healthcare workers point of view: survey results and a narrative review from the global accelerator for paediatric formulations project;Frontiers in Pharmacology;2023-07-17

3. Pharmacokinetics and Drug-Drug Interactions of Abacavir and Lamuvudine Co-administered With Antituberculosis Drugs in HIV-Positive Children Treated for Multidrug-Resistant Tuberculosis;Frontiers in Pharmacology;2021-10-08

4. Abacavir pharmacokinetics in African children living with HIV: A pooled analysis describing the effects of age, malnutrition and common concomitant medications;British Journal of Clinical Pharmacology;2021-08-12

5. Abacavir Exposure in Children Cotreated for Tuberculosis with Rifampin and Superboosted Lopinavir-Ritonavir;Antimicrobial Agents and Chemotherapy;2020-04-21